Neuro Vigor Competitors and Similar CompaniesClear all
ACADIA Pharmaceuticals's competitors and similar companies include Shionogi.
 ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. | |
Founding Date | Founding Date 1993 | Founding Date 1878 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Princeton, US | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more |
Employees | Employees 513 | Employees 4,955 |
Valuation ($) | Valuation ($) 2.4 b | Valuation ($) 12.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) ¥499.7b (FY, 2026) |
Cost of goods | Cost of goods $89m (FY, 2025) | Cost of goods ¥55.5b (FY, 2026) |
Gross profit | Gross profit $982.5m (FY, 2025) | Gross profit ¥491.3b (FY, 2026) |
Net income | Net income $391m (FY, 2025) | Net income ¥205.9b (FY, 2026) |
Funding | ||
Total funding raised | Total funding raised $ 770.8m | Total funding raised $ 4.7m |
For sources of this data, please see the company profile
View Company Profiles
Shionogi
HQ
Osaka, JP
Employees
4,955
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View company